BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA
May 3, 2023
More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious… Read More
© 2024 CSRXP- All Rights Reserved
Updates
BIG PHARMA WATCH: BIG PHARMA SPENT $8.1 BILLION ON ADS PUSHING HIGH-PRICED BRAND NAME PRESCRIPTION DRUGS IN 2022
May 1, 2023
Big Pharma Spending Binge Underscores Bipartisan Support for List Price… Read More
DOSE OF REALITY: LIST PRICE TRANSPARENCY WILL HELP HOLD BIG PHARMA ACCOUNTABLE AND LOWER PRESCRIPTION DRUG PRICES FOR PATIENTS
Apr 25, 2023
Congress Should Advance Bipartisan, Market-Based Measures to Increase… Read More
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON
Apr 24, 2023
Big Pharma Giant Kicks Off Q1 Earnings By Boasting “Strategic Price… Read More
DOSE OF REALITY: EXPERT ASSESSMENT CONFIRMS BIG PHARMA’S PRICING OF NEW ALZHEIMER’S TREATMENT EXCEEDS FAIR PRICE
Apr 18, 2023
ICER Analysis of Leqembi Finds $26,500 Price Tag Exceeds Drug’s “Cost… Read More
ICYMI: LAWMAKERS MAKE BIPARTISAN CALL FOR FURTHER ACTION TO CRACK DOWN ON BIG PHARMA’S PATENT THICKETS
Mar 28, 2023
Members of Congress Send Letter Encouraging USPTO to Close Loopholes Exploited… Read More
CSRXP APPLAUDS REINTRODUCTION OF FAIR DRUG PRICING ACT
Mar 24, 2023
Bipartisan Transparency Legislation Will Help Hold Big Pharma Accountable for… Read More
THEY SAID IT! LAWMAKERS SLAM MODERNA FOR EGREGIOUS COVID-19 VACCINE PRICE HIKE
Mar 23, 2023
Senate HELP Committee Members Slam Moderna’s CEO for Instituting Nearly 500… Read More
CSRXP: LAWMAKERS MUST HOLD BIG PHARMA ACCOUNTABLE FOR UNCONSCIONABLE PRICE HIKES ON COVID-19 VACCINES AND TREATMENTS
Mar 22, 2023
Senate HELP Committee Hearing with Moderna CEO Offers Prime Opportunity to… Read More
DOSE OF REALITY: LAWMAKERS GET CHANCE TO HOLD BIG PHARMA ACCOUNTABLE FOR COVID-19 PRICE-GOUGING AHEAD OF COMMERCIAL DISTRIBUTION
Mar 20, 2023
Senate HELP Committee to Question Moderna CEO on Nearly 500 Percent Price Hike… Read More
BIRDS OF A FEATHER: PFIZER AND SANOFI ACQUIRE FELLOW PRICE-GOUGERS IN LATEST BIG PHARMA M&A DEALS
Mar 17, 2023
Big Pharma Giants With Affinity for Price Hikes Acquire Smaller Brand Name… Read More
BIG PHARMA WATCH: NEW REPORT HIGHLIGHTS BIG PHARMA’S RAPIDLY RISING LAUNCH PRICES
Mar 10, 2023
Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved… Read More